Literature DB >> 11087381

Enhanced gamma-carboxylation of recombinant factor X using a chimeric construct containing the prothrombin propeptide.

R M Camire1, P J Larson, D W Stafford, K A High.   

Abstract

Factor Xa is the serine protease component of prothrombinase, the enzymatic complex responsible for thrombin generation. Production of recombinant factor X/Xa has proven to be difficult because of inefficient gamma-carboxylation, a critical post-translational modification. The affinities of the vitamin K-dependent propeptides for the gamma-carboxylase vary over 2 logs, with the propeptide of factor X having the highest affinity followed by the propeptides of factor VII, protein S, factor IX, protein C, and prothrombin [Stanley, T. B. (1999) J. Biol. Chem. 274, 16940-16944]. On the basis of this observation, it was hypothesized that exchanging the propeptide of factor X with one that binds the gamma-carboxylase with a reduced affinity would enhance gamma-carboxylation by allowing greater substrate turnover. A chimeric cDNA consisting of the human prothrombin signal sequence and propeptide followed by mature human factor X was generated and stably transfected into HEK 293 cells, and modified factor X was purified from conditioned medium. The results indicate that on average 85% of the total factor X produced with the prothrombin propeptide was fully gamma-carboxylated, representing a substantial improvement over a system that employs the native factor X propeptide, with which on average only 32% of the protein is fully gamma-carboxylated. These results indicate that the affinity of the gamma-carboxylase for the propeptide greatly influences the extent of gamma-carboxylation. It was also observed that regardless of which propeptide sequence is directing gamma-carboxylation (factor X or prothrombin), two pools of factor X are secreted; one is uncarboxylated and a second is fully gamma-carboxylated, supporting the notion that the gamma-carboxylase is a processive enzyme.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087381     DOI: 10.1021/bi001074q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Ratcheting of the substrate from the zymogen to proteinase conformations directs the sequential cleavage of prothrombin by prothrombinase.

Authors:  Elsa P Bianchini; Steven J Orcutt; Peter Panizzi; Paul E Bock; Sriram Krishnaswamy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

2.  Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase.

Authors:  Ayse Hacisalihoglu; Peter Panizzi; Paul E Bock; Rodney M Camire; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2007-09-11       Impact factor: 5.157

3.  The endothelial protein C receptor enhances hemostasis of FVIIa administration in hemophilic mice in vivo.

Authors:  Giulia Pavani; Lacramioara Ivanciu; Armida Faella; Oscar A Marcos-Contreras; Paris Margaritis
Journal:  Blood       Date:  2014-06-23       Impact factor: 22.113

4.  Characterization of vitamin K-dependent carboxylase mutations that cause bleeding and nonbleeding disorders.

Authors:  Jian-Ke Tie; Jorge D A Carneiro; Da-Yun Jin; Ciro D Martinhago; Cees Vermeer; Darrel W Stafford
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

5.  A rapid pro-hemostatic approach to overcome direct oral anticoagulants.

Authors:  Nabil K Thalji; Lacramioara Ivanciu; Robert Davidson; Phyllis A Gimotty; Sriram Krishnaswamy; Rodney M Camire
Journal:  Nat Med       Date:  2016-07-25       Impact factor: 53.440

6.  Exosite binding drives substrate affinity for the activation of coagulation factor X by the intrinsic Xase complex.

Authors:  Manjunath Goolyam Basavaraj; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2020-08-28       Impact factor: 5.157

7.  Improved activity and expression of recombinant human factor IX by propeptide engineering.

Authors:  Jafar Vatandoost; Mettine H A Bos
Journal:  Daru       Date:  2019-10-21       Impact factor: 3.117

8.  Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats.

Authors:  Shannon M Zintner; Juliana C Small; Giulia Pavani; Lynn Dankner; Oscar A Marcos-Contreras; Phyllis A Gimotty; Mads Kjelgaard-Hansen; Bo Wiinberg; Paris Margaritis
Journal:  Blood Adv       Date:  2019-02-12

9.  Fate of membrane-bound reactants and products during the activation of human prothrombin by prothrombinase.

Authors:  Parvathi Kamath; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

10.  Regulated cleavage of prothrombin by prothrombinase: repositioning a cleavage site reveals the unique kinetic behavior of the action of prothrombinase on its compound substrate.

Authors:  Harlan N Bradford; Joseph A Micucci; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.